Financing
Repayments of Short-Term Debt
Year-over-year, this metric declined by 76.1%, from $1.08B to $259.00M.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2017
Last reportedQ1 2026May 1, 2026
How to read this metric
High repayment levels indicate the firm is successfully deleveraging or rolling over short-term obligations.
Detailed definition
This represents cash outflows used to settle short-term debt obligations, including commercial paper and other borrowing...
Peer comparison
Standard for all firms with active treasury management; should be viewed alongside issuance levels.
Metric ID:
financing_repayments_of_short_term_debtHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $250.00M | $0.00 | $0.00 | $0.00 | $0.00 | $504.00M | $1.08B | $500.00M | $12.00M | $0.00 | $259.00M |
| QoQ Change | — | — | — | — | -100.0% | — | — | — | — | +114.9% | -53.8% | -97.6% | -100.0% | — |
| YoY Change | — | — | — | — | -100.0% | — | — | — | — | +114.9% | — | — | — | -76.1% |
Range$0.00 – $1.08B
Avg YoY Growth-20.4%
Median YoY Growth-76.1%
Current Streak4 quarters decline
Repayments of Short-Term Debt at Other Companies
Frequently Asked Questions
- What is Boston Scientific's repayments of short-term debt?
- Boston Scientific (BSX) reported repayments of short-term debt of $259.00M in Q1 2026.
- How has Boston Scientific's repayments of short-term debt changed year-over-year?
- Boston Scientific's repayments of short-term debt decreased by 76.1% year-over-year, from $1.08B to $259.00M.
- What does repayments of short-term debt mean?
- Cash paid to settle debt obligations that were due within one year.